Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...

Inflammatory Bowel Disease (IBD) is a term for chronic inflammatory conditions affecting the digestive tract, primarily Crohn ...

Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...

The study's primary goal is to assess the therapy’s tolerability, pharmacokinetics and safety in healthy volunteers.

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Odyssey Therapeutics (ODTX), which is developing treatments for inflammatory bowel disease, has filed for a $100M initial ...

Analysts at Lifesci Capital upped their FY2024 earnings per share estimates for Spyre Therapeutics in a report released on Tuesday, January 14th. Lifesci Capital analyst S. Slutsky now anticipates ...

The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...

Gloomy economic data did little to suppress London stocks this week, as a bumper performance across the board saw a heap of ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

Our gut is a bustling hub of activity, home to trillions of microbes that work together with our bodies to keep us healthy. A recent study explores one fascinating aspect of this partnership: how gut ...

Stock analysts at Zacks Research decreased their FY2024 EPS estimates for AbbVie in a research report issued to clients and investors on Wednesday, January 15th. Zacks Research analyst S. Ganoria now ...